BTA
Click for more information
0.00% 57.0¢ biota holdings limited

GSK will increase anti-viral (Relenza)production rapidly, at the...

  1. heydv
    107 Posts.
    clock Created with Sketch.
    30/01/10
    12:18
    Post #: 6265338
    GSK will increase anti-viral (Relenza)production rapidly, at the expense of flu-vaccine.
    BTA Price at posting: $2.00 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.